AZILSARTAN AS A POTENT ANTIHYPERTENSIVE DRUG WITH POSSIBLE PLEIOTROPIC CARDIOMETABOLIC EFFECTS: A REVIEW STUDY.

Background: Hypertension related cardiovascular (CV) complications could be amplified by the presence of metabolic co-morbidities. Azilsartan medoxomil (AZL-M) is the eighth approved member of angiotensin II receptor blockers (ARBs), a drug class of high priority in the management of hypertensive su...

Full description

Saved in:
Bibliographic Details
Main Authors: Georgiopoulos Georgios (Author), Vasiliki Katsi (Author), Dimitrios Oikonomou (Author), Georgia Vamvakou (Author), Evangelia Koutli (Author), Aggeliki Laina (Author), Constantinos Tsioufis (Author), Petros Nihoyannopoulos (Author), Dimitrios Tousoulis (Author)
Format: Book
Published: Frontiers Media S.A., 2016-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available